3B Pharmaceuticals GmbH / MetrioPharm AG / Novartis / High / Berlin Cures GmbH / Glycotope GmbH / InterMune GmbH / Organobalance Medical AG / NOXXON Pharma AG / Adrenomed AG / At 3B Pharmaceuticals / Myelo Therapeutics AudioCure Pharma GmbH / ALRISE Biosystems / CellTrend / Eternygen GmbH / Berlin-Brandenburg 15 Contract Manufacturing Organizations Partners / German Stock Exchange / JPT / Biotech Companies P Preclinic MerLion Pharmaceuticals GmbH / Quark / OctreoPharma Sciences GmbH / Omeicos Therapeutics GmbH / Amal Therapeutics S.A. / MOLOGEN AG / Pfizer / Silence Therapeutics AG / Service Providers Service Providers Vital Partners / Medien GmbH / Service Providers Vital Partners / Charité Vivantes GmbH / EVESTRA GmbH / /
Continent
Europe / /
Country
Germany / United States / / /
Event
Business Partnership / FDA Phase / /
Facility
Biotech Product Pipeline / / /
IndustryTerm
biopharmaceutical problems / allogeneic tumor cell bank / antibody-based detection systems / pharmaceutical development value chain / platform technology / exploitation chain / energy / medical technology / real estate / active ingredient transport technologies / pharmaceuticals industry / pharmaceuticals / pharmaceutical and medical technology / technology platforms / targeted radiotherapeutics / feasible solutions / treatment of renal cancer / technology parks / peptide products / clinical diagnostic applications / biotechnology / healthcare industries area / pharmaceutical / healthcare / diagnostic products / manufacturing arm / parenteral deposit pharmaceuticals forms / treatment for cancer / treatment of colorectal cancer / clinical-stage product / pharmaceutical impurities / /
MedicalCondition
II systemic sclerosis-related interstitial lung disease II / ovarian cancer / multiple myeloma / gastric and other cancers II / rheumatoid arthritis / leishmaniasis / renal cancer / non-small cell lung cancer / psoriasis / hematologic tumors / cardiovascular diseases / pancreatic adenocarcinoma / tumor / sensory and neurological ear diseases / anemic cancer / cancer / chronic lymphocytc leukemia / multiple myelomas / idiopathic pulmonary fibrosis / neutropenia / diabetes / migraine II / chronic disease / dietary-related metabolic diseases / atrial fibrillation / inflammatory disease / tinnitus / fibrosis / otitis / colorectal cancer / metastasis / III colorectal cancer P / solid tumors / thrombocytopenia / P severe sepsis I / CIN / human glioblastoma multiform Myelo Therapeutics AudioCure Pharma GmbH Compound / pancreatic cancer / sepsis / P chronic heart failure P / haemophilia I / diabetic nephropathy / P neuroendocrine tumours / vertigo / cardiovascular disease / P dietary-related metabolic diseases / chronic lymphatic leukemia / allogeneic tumor / P endometriosis / lung cancer / infectious diseases / P noise-induced hearing loss / DNA cancer / anemia / /
MedicalTreatment
vaccination / fertility control / chemotherapy / hemodialysis / /
Organization
Center for Molecular Medicine in Berlin / Max Delbrück Center / German parliament / /
Person
Silke Osswald / Alexis Puentes / Cornelia Bauer / Kate Abbott / Sven Klussmann / Volker Erb / / /
Spiegelmers / polyethylene glycol / Spiegelmer platform / Spiegelmer / I Phase I Compound / /
Technology
proteomics / anti-infectives / drug delivery / biopharmaceuticals / DRUG DISCOVERY / chemotherapy / platform technologies / antibodies / Biotechnology / GlycoBody technologies / pharmaceutical and medical technology / platform technology / active ingredient transport technologies / drug development / regenerative medicine / /
BIOTOPics DRUG DISCOVERY AND DEVELOPMENT POTENTIALS – PROFILES – PERSPECTIVES Journal of Biotechnology in Berlin-Brandenburg